文献速递免疫规划卫生政策与健康促进

中国社交媒体提示中国疫苗接受度下降:2018年长春长生疫苗事件后微博观察性研究

Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident.
PubMed 文献 · Vaccine · 2020-02-22

研究分析2018年7月(n=11,085)和2019年8月(n=500)新浪微博消息,追踪长春长生疫苗事件前后中国疫苗接受度。结果显示事件期间及之后对政府疫苗的不信任表达显著增加,疫苗接种自我报告从正面认可转为对疫苗危害的担忧,数据提示中国疫苗接受度可能正在下降。

要点

  • 事件期间及之后对政府疫苗不信任表达显著增加。
  • 疫苗接种自我报告从正面认可转为担忧疫苗危害。
  • 数据提示中国疫苗接受度可能正在下降。

核心结论

  • 数据提示中国疫苗接受度可能正在下降。

研究设计与样本

  • 观察性研究,分析新浪微博2018年7月(n=11,085)和2019年8月(n=500)消息。

主要发现

  • 事件期间及之后对政府疫苗不信任表达显著增加。
  • 疫苗接种自我报告在事件前和事件一年后均出现,但从正面认可转为担忧疫苗危害。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

China is home to the world's largest population, with the potential for disease outbreaks to affect billions. However, knowledge of Chinese vaccine acceptance trends is limited. In this work we use Chinese social media to track responses to the recent Changchun Changsheng Biotechnology vaccine scandal, which led to extensive discussion regarding vaccine safety and regulation in China. We analyzed messages from the popular Chinese microblogging platform Sina Weibo in July 2018 (n = 11,085), and August 2019 (n = 500). Thus, we consider Chinese vaccine acceptance, before, during, immediately after, and one year after the scandal occurred. Results show that expressions of distrust in government pertaining to vaccines increased significantly during and immediately after the scandal. Self-reports of vaccination occurred both before, and one year after, the scandal; however, these self-reports changed from positive endorsements of vaccination to concerns about vaccine harms. Data suggest that expressed support for vaccine acceptance in China may be decreasing.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hu D, Martin C, Dredze M, et al. Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident. Vaccine. 2020. PMID: 32093982. doi:10.1016/j.vaccine.2020.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。